Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Avai Bio (AVAI) EBITDA Margin (2019 - 2020)

Avai Bio's EBITDA Margin history spans 2 years, with the latest figure at 278.81% for Q4 2020.

  • On a quarterly basis, EBITDA Margin changed N/A to 278.81% in Q4 2020 year-over-year; TTM through Dec 2020 was 1.77%, a 100145.0% increase, with the full-year FY2023 number at 127.35%, changed N/A from a year prior.
  • EBITDA Margin hit 278.81% in Q4 2020 for Avai Bio, up from 10.21% in the prior quarter.
  • Over the last five years, EBITDA Margin for AVAI hit a ceiling of 278.81% in Q4 2020 and a floor of 208.85% in Q2 2019.